Page last updated: 2024-09-05

dapivirine and HIV Infections

dapivirine has been researched along with HIV Infections in 122 studies

Research

Studies (122)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	13 (10.66)	29.6817
2010's	53 (43.44)	24.3611
2020's	56 (45.90)	2.80

Authors

Authors	Studies
Andries, K; Arnold, E; Bohets, H; Clark, AD; Daeyaert, F; Das, K; de Béthune, MP; De Clerck, F; de Jonge, M; De Knaep, F; Frenkel, YV; Guillemont, J; Heeres, J; Hughes, SH; Janssen, PA; Koymans, L; Kukla, M; Lampo, A; Lewi, PJ; Ludovici, D; Medaer, B; Pasquier, E; Pauwels, R; Stoffels, P; Vinkers, M; Williams, P	1
Armanasco, N; Azijn, H; de Bethune, MP; Fletcher, P; Harman, S; Manlow, P; Nuttall, J; Perumal, D; Romano, J; Shattock, R	1
Anton, P; Cranage, M; Herrera, C; McGowan, I; Shattock, RJ	1
Chen, CH; Jiang, S; Lai, W; Lee, KH; Lu, H; Qin, B; Tian, X; Xie, L	1
Gu, SX; Ju, XL; Liu, GY; Lu, HH; Zhu, YY	1
Bauermeister, J; Brand, RM; Brown, E; Cranston, RD; Devlin, B; Dezzutti, CS; Dominguez-Islas, C; Dunne, EF; Gundacker, H; Hendrix, CW; Ho, K; Hoesley, C; Jacobson, CE; Johnson, S; Kramzer, L; Kunjara Na Ayudhya, RP; Lucas, J; Marzinke, MA; McGowan, I; Nuttall, J; Peda, M; Piper, J; Singh, D; Wang, L	1
Baeten, JM; Hartmann, M; Lanham, M; Mathebula, F; Montgomery, ET; Palanee-Phillips, T; Reddy, K; Roberts, ST; Tolley, E; Wagner, LD; Wilcher, R; Wilson, E; Zissette, S	1
Bauermeister, JA; Devlin, B; Dezzutti, CS; Dominguez-Islas, C; Hendrix, CW; Ho, K; Jacobson, CE; Johnson, S; Kramzer, L; Kunjara Na Ayudhya, RP; Lucas, J; Macagna, N; Ngo, J; Piper, J; Singh, D; Szydlo, D; Tingler, RC	1
Ayudhya, RPKN; Bauermeister, JA; Brown, E; Cranston, RD; Devlin, B; Dezzutti, CS; Dominguez, C; Dunne, EF; Gundacker, H; Hendrix, CW; Ho, K; Hoesley, C; Jacobson, CE; Johnson, S; Kramzer, L; Lucas, J; Macagna, N; Marzinke, MA; McGowan, I; Nuttall, J; Peda, M; Piper, J; Singh, D; Tingler, RC	1
Armstrong, R; Bashi, YHD; Boyd, P; Derrick, T; Devlin, B; Lim, D; Malcolm, RK; McCoy, CF; Murphy, DJ; Spence, P	1
Duby, Z; Etima, J; Garcia, M; Katz, AWK; Manengamambo, E; Mansoor, LE; Mathebula, F; Montgomery, ET; Naidoo, S; Palanee-Phillips, T; Reddy, K; Singh, D; Soto-Torres, L; Zimba, C	1
Baeten, JM; Fleurs, L; Gaffoor, Z; Garcia, M; Gondwe, DK; Jeenarain, N; Kemigisha, D; Kiweewa, FM; Luecke, E; Makala, Y; Mansoor, LE; Mayo, AJ; Morar, NS; Musara, P; Ndase, P; Palanee-Phillips, T; Reddy, K; Scheckter, R; Singh, N; Soto-Torres, L; Torjesen, K; van der Straten, A; Woeber, K	1
Baeten, JM; Chandran, U; Goetz, BJ; Gordon, KC; Halvas, EK; Hardesty, R; Heaps, AL; Husnik, MJ; Mellors, JW; Palanee-Phillips, T; Parikh, UM; Penrose, KJ; Schwarzmann, W; Sethi, R; Szydlo, DW	1
Bhavaraju, N; Jeckonia, P; Mullick, S; Murungu, J; Persaud, U; Schwartz, K; Shears, K; Torjesen, K; Vij, A	1
Chitukuta, M; Garcia, M; Katz, A; Luecke, E; Mansoor, LE; Mathebula, F; Montgomery, ET; Morar, N; Naidoo, S; Palanee-Phillips, T; Reddy, K; Tenza, S; Tsidya, M	1
Chen, BA; Hoesley, C; Johnson, S; Laborde, N; Luecke, E; Nel, A; Salata, RA; Shapley-Quinn, MK; Soto-Torres, L; van der Straten, A	1
Baeten, JM; Brown, ER; Browne, EN; Husnik, MJ; Jeenarain, N; Naidoo, L; Nair, G; Palanee-Phillips, T; Reddy, K; Scheckter, R; Singh, D; Soto-Torres, L; van der Straten, A	1
Atujuna, M; Baeten, JM; Balán, IC; Etima, J; Katz, AWK; Mgodi, N; Ngure, K; Palanee-Phillips, T; Reddy, K; Scheckter, R; Soto-Torres, L; Tauya, T; van der Straten, A; Weber, K	1
Katz, AW; Krishnaveni, R; Leila, ME; Lydia, ST; Morgan, G; Naidoo, K; Sarita, N; T, ME	1
Gollub, EL; Vaughan, R	1
Akello, CA; Baeten, JM; Brown, ER; Cabrera, MV; Chinula, L; Cobbing, M; Dadabhai, S; Mansoor, LE; Mayo, AJ; Mgodi, NM; Mirembe, BG; Nair, G; Nakabiito, C; Nakalega, R; Palanee-Phillips, T; Siva, S; Soto-Torres, LE; van der Straten, A	1
Baeten, JM; Barnabas, RV; Brown, ER; Harkoo, I; Hendrix, CW; Hillier, SL; Jeenarain, N; Mirembe, BG; Palanee-Phillips, T; Peebles, K; Reddy, K; van der Straten, A	1
Craig, C; Mellors, J; Nuttall, J; Parikh, U; Steytler, J; Van Baelen, B; van der Ryst, E; van Niekerk, N; Wallis, C	2
Bauermeister, J; Brand, RM; Dominguez-Islas, C; Edick, S; Hendrix, CW; Hillier, SL; Ho, K; Jacobson, CE; Kramzer, L; Kunjara Na Ayudhya, RP; Macagna, N; Marzinke, MA; Nuttall, J; Piper, J; Riddler, SA; Szydlo, D	1
Duma, C; Garcia, M; Katz, AWK; Mansoor, LE; Montgomery, ET; Morar, NS; Naidoo, K; Naidoo, S; Precious Myeni, NB; Tshbalala, T	1
Akello, CA; Celum, C; Friedland, BA; Garcia, M; Hillier, SL; Hosek, S; Levy, L; Macdonald, P; Nair, G; Ngure, K; Palanee-Phillips, T; Reddy, K; Roberts, ST; Siziba, B; Soto-Torres, L; Szydlo, DW; van der Straten, A	1
Atujuna, M; Chitukuta, M; Garcia, M; Kemigisha, D; Mancuso, N; Ngure, K; Roberts, ST; Soto-Torres, L; Szydlo, D; Tenza, S; van der Straten, A; Young, AM	1
Balkus, JE; Dandadzi, A; Etima, J; Fabiano, Z; Hawley, I; Horne, E; Kemigisha, D; Mathebula, F; Montgomery, ET; Mutero, P; Noguchi, L; Owor, M; Scheckter, R; Seyama, L; Stoner, MCD	1
Baeten, JM; Chandran, U; Goetz, BJ; Heaps, AL; Mellors, JW; Mgodi, NM; Palanee-Phillips, T; Parikh, UM; Penrose, KJ; Sethi, R; Szydlo, D	1
Akello, CA; Anderson, P; Baeten, JM; Bekker, LG; Brown, ER; Bunge, K; Celum, C; Garcia, M; Hendrix, C; Hillier, SL; Hosek, S; Jacobson, C; Johnson, S; Levy, L; Livant, E; Macdonald, P; McClure, T; Milan, G; Muhlanga, F; Nair, G; Nakabiito, C; Nakalega, R; Ngure, K; Palanee-Phillips, T; Parikh, U; Reddy, K; Rooney, JF; Siziba, B; Soto-Torres, L; Steytler, J; Szydlo, D; Tahuringana, E; van der Straten, A	1
Bashi, YD; Boyd, P; Coulter, S; Laverty, G; Malcolm, RK; McCoy, CF; Murphy, DJ; Zhao, X	1
Balkus, JE; Bunge, K; Chakhtoura, N; Chappell, CA; Fairlie, L; Gadama, L; Hillier, SL; Matrimbira, M; Mayo, AJ; Mgodi, N; Nakabiito, C; Piper, J; Richardson, B; Szydlo, DW	1
Baeten, JM; Palanee-Phillips, T	1
Baeten, JM; Gaffoor, Z; Govender, V; Kabwigu, S; Matovu Kiweewa, F; Montgomery, ET; Naidoo, K; Nair, G; Palanee-Philips, T; Reddy, K; Roberts, ST; Schwartz, K; Singh, N; Siva, S	1
Guerrero-Beltrán, C; Jiménez, JL; Leal, M; Muñoz-Fernández, MÁ; Prieto, A	1
Baeten, JM; Bekker, LG; Brown, ER; Bunge, K; Chinula, L; Chirenje, Z; Jeenarain, N; Kelly, C; Kiweewa, FM; Makanani, B; Marrazzo, J; Mgodi, N; Naidoo, L; Nair, G; Palanee-Phillips, T; Piper, J; Reddy, K; Siva, S; Soto-Torres, L	1
Baeten, JM; Brown, ER; Gati Mirembe, B; Harkoo, I; Hendrix, CW; Hillier, SL; Jeenarain, N; Palanee-Phillips, T; Peebles, K; Reddy, K; van der Straten, A	1
Manohar, M; Marzinke, MA	1
Bunge, KE; Futterman, D; Gaur, AH; Gorbach, PM; Hendrix, CW; Hillier, SL; Hoesley, C; Kapogiannis, B; Levy, L; Marzinke, MA; Mayer, KH; Nel, A; Reirden, D; Soto-Torres, L; Squires, KE; Szydlo, DW; Wilson, CM; Zhang, J	1
Chitukuta, M; Katz, AWK; Montgomery, ET; Nabukeera, J; Naidoo, K; Reddy, K; Siva, S; Zimba, C	1
Beksinska, M; Frezieres, R; Greener, R; Malherbe, M; Nel, A; Smit, J; van Niekerk, N; Walsh, T	1
Asiimwe, FB; Baeten, JM; Balán, IC; Byogero, R; Chetty, D; Giguere, R; Jambaya, J; Kajura-Manyindo, C; Khanyile, N; Kutner, BA; Lentz, C; Makala, Y; Mayo, A; Mgodi, NM; Palanee-Phillips, T; Soto-Torres, L	1
Avenant, C; Dlamini, S; Enfield, K; Hapgood, JP; Kuipa, M	1
Bunge, KE; Burgener, A; Dezzutti, C; Farr Zuend, C; Hillier, SL; Hoger, S; Marrazzo, J; McCorriser, S; Noël-Romas, L; Squires, K; Westmacott, G	1
Baeten, JM; Bekker, LG; Brown, ER; Hendrix, CW; Hillier, SL; Kiweewa, FM; Marzinke, MA; Mgodi, NM; Palanee-Philips, T; Soto-Torres, L; van der Straten, A	1
Chitukuta, M; Garcia, M; Katz, AWK; Kemigisha, D; Mansoor, LE; Montgomery, ET; Morar, NS; Naidoo, K; Naidoo, S; Reddy, K; Soto-Torres, L; Zimba, CC	1
Chitukuta, M; Duby, Z; Garcia, M; Guma, V; Katz, AWK; Leslie, J; Mansoor, LE; Montgomery, ET; Morar, NS; Naidoo, K; Naidoo, S; Tenza, S; Tsidya, M	1
Bekker, LG; Carter, A; Craig, C; Devlin, B; Gill, K; Gwetu, T; Kotze, P; Kusemererwa, S; Louw, C; Mabude, Z; Malherbe, M; Mans, W; Moraba, R; Nel, A; Rosenberg, Z; Steytler, J; Tempelman, H; Van Baelen, B; van der Ryst, E; van Niekerk, N	1
Baeten, JM; Balán, IC; Brown, ER; Bunge, K; Chinula, L; Chirenje, ZM; Garcia, M; Gati Mirembe, B; Govender, V; Hendrix, CW; Hillier, SL; Hunidzarira, P; Jacobson, C; Jiao, Y; Jones, J; Livant, E; Makanani, B; Mansoor, LE; Mayo, AJ; Mellors, JW; Mgodi, NM; Mhlanga, F; Naidoo, L; Nair, G; Nakabiito, C; Nel, A; Ngure, K; Palanee-Phillips, T; Parikh, UM; Patterson, K; Peda, M; Ramjee, G; Rosenberg, Z; Scheckter, R; Singh, D; Singh, N; Siva, S; Soto-Torres, LE; Szydlo, DW; Taha, TE; Torjesen, K; van der Straten, A	1
Abaasa, A; Kabarambi, A; Kusemererwa, S; Mugisha, JO; Onyango, M	1
Fried, JR; Fuqua, JL; Minooei, F; Palmer, KE; Steinbach-Rankins, JM	1
Baeten, JM; Brown, ER; Browne, EN; Chitukuta, M; Gati Mirembe, B; Harkoo, I; Jeenarain, N; Mayo, AJ; Montgomery, ET; Mutero, P; Palanee-Phillips, T; Reddy, K; Seyama, L; Soto-Torres, L; Tauya, T; Tembo, T; Torjesen, K; van der Straten, A; Woeber, K	1
Mwethera, PG; Obiero, J; Ogongo, P; Wiysonge, CS	1
Asiimwe, F; Balán, IC; Dolezal, C; Giguere, R; Kajura-Manyindo, C; Kutner, BA; Lentz, C; Madlala, B; Mugocha, C; Mwenda, W; Naidu, N; Ndlovu, T; Yambira, M	1
Hunter, LA; Liu, JX; McCoy, SI; Mfaume, R; Njau, P; Packel, L; Ramadhani, AA; Tubert, J	1
Akello, C; Brown, ER; Chitukuta, M; Hunidzarira, P; Jeenarain, N; Mansoor, LE; Mgodi, N; Naidoo, L; Nair, G; Palanee-Phillips, T; Seyama, L; Stoner, MCD; Tembo, T; van der Straten, A	1
Etima, J; Gichane, MW; Katz, AWK; Mangxilana, N; Ngure, K; Palanee-Phillips, T; Reddy, K; Scheckter, R; Tauya, T; van der Straten, A; Woeber, K; Zimba, C	1
Baeten, JM; Brown, ER; Dadabhai, SS; Gaffoor, Z; Husnik, MJ; Jeenarain, N; Kiweewa, FM; Livant, E; Mansoor, LE; Mirembe, BG; Palanee-Phillips, T; Singh, D; Siva, S; Soto-Torres, L; van der Straten, A	1
Beamer, M; Bunge, K; Devlin, B; Dominguez Islas, C; Gundacker, H; Harrell, T; Hendrix, CW; Hoesley, C; Jacobson, CE; Liu, AY; Marzinke, MA; McClure, T; Neradilek, B; Nuttall, J; Piper, JM; Spence, P; Steytler, J; van der Straten, A	1
Akello, C; Chitowa, TH; Garcia, M; Katz, AWK; Mansoor, LE; Mathebula, F; Montgomery, ET; Singh, D; Siva, S; Soto-Torres, L; Tsidya, M	1
Atujuna, M; Baeten, JM; Bekker, LG; Chitukuta, M; Etima, J; Grossman, CI; Katz, A; Laborde, N; Mayo, AJ; Montgomery, ET; Nakyanzi, T; Palanee-Phillips, T; Reddy, K; Soto-Torres, L; van der Straten, A; Woeber, K	1
Boyd, P; Derrick, T; Devlin, B; Malcolm, RK; McCoy, CF; Murphy, DJ; Spence, P	1
Giacobbi, NS; Sluis-Cremer, N	1
Baeten, JM; Balkus, JE; Brown, ER; Chappell, C; Harkoo, I; Jeenarain, N; Kabwigu, S; Kintu, K; Kiweewa, FM; Marzinke, M; Naidoo, L; Nair, G; Nakabiito, C; Palanee-Phillips, T; Reddy, K; Siva, S; Soto-Torres, L	1
Mack, N; MacQueen, KM; Moench, T; Okumu, E; Owen, DH; Stalter, RM; Tharaldson, J; Tolley, EE	1
Baeten, JM; Brown, ER; Hendrix, CW; Hillier, SL; Husnik, MJ; Livant, E; Marzinke, M; Matovu Kiweewa, F; Nair, G; Palanee-Phillips, T; Schwartz, K; Soto-Torres, LE	1
Baeten, JM; Balkus, JE; Brown, ER; Gaffoor, Z; Jeenarain, N; Matovu Kiweewa, F; Mbilizi, Y; Mgodi, N; Naidoo, L; Nair, G; Palanee-Phillips, T; Pather, A; Siva, S	1
Abdool Karim, SS; Baxter, C; Passmore, JS	1
Atujuna, M; Baeten, JM; Chitukuta, M; Laborde, ND; Montgomery, ET; Naidoo, S; Nakyanzi, T; Palanee-Phillips, T; Pleasants, E; Reddy, K	1
Bies, R; Kay, K; Rohan, L; Shah, DK	1
Chitukuta, M; Etima, J; Garcia, M; Katz, AWK; Laborde, N; Mansoor, LE; Montgomery, ET; Naidoo, S; Reddy, K; Soto-Torres, L; Stadler, J; Zimba, C	1
Cameron, SA; Cheshenko, N; Frank, B; Fredricks, D; Herold, BC; Keller, MJ; Mesquita, PM; Reagle, K; Sinclair, S; Srinivasan, S; Taneva, E; Weinrick, B	1
Baeten, JM; Brown, ER; Husnik, M; Kiweewa, FM; Mayo, AJ; Mensch, BS; Palanee-Phillips, T; Richardson, BA; van der Straten, A	1
Baeten, J; Brown, E; Gafoor, Z; Govender, V; Hlahla, K; Makanani, B; Matovu, F; Montgomery, ET; Naidoo, L; Nair, G; Palanee-Phillips, T; Pather, A; Reddy, K; Roberts, ST; Schwartz, K; Siva, S; Soto-Torres, L; Torjesen, K	1
Akello, C; Baeten, JM; Balkus, JE; Dadabhai, S; Heaps, AL; Livant, E; Mayo, AJ; Mellors, JW; Mhlanga, F; O'Rourke, C; Parikh, UM; Ramjee, G; Riddler, SA	1
Baeten, JM; Balkus, JE; Beigi, R; Harkoo, I; Jeenariain, N; Jiao, Y; Kabwigu, S; Kintu, K; Makanani, B; Mbilizi, Y; Mgodi, N; Moodley, J; Noguchi, LM; Palanee-Phillips, T; Piper, J; Reddy, K; Rees, H; Scheckter, R	1
Beigi, RH; Bogen, DL; Bunge, K; Dezzutti, CS; Hendrix, CW; Hillier, SL; Hoesley, C; Kelly, C; Marzinke, MA; Nel, A; Noguchi, LM; Piper, JM; Scheckter, R	1
Chitukuta, M; Duby, Z; Etima, J; Katz, A; Mgodi, NM; Musara, P; Nakyanzi, T; Palanee-Phillips, T; Reddy, K; Tembo, T; van der Straten, A	1
Baeten, JM; Brown, ER; Browne, EN; Mensch, B; Palanee-Phillips, T; Reddy, K; Scheckter, R; Shapley-Quinn, MK; Soto-Torres, L; van der Straten, A	1
Boyd, P; Cameron, D; Devlin, B; Dias, N; Hartley, O; Kett, VL; Malcolm, RK; McBride, JW; Offord, RE	1
Abbas, UL; Ding, Y; Engquist, E; Glaubius, R; Hood, G; Mellors, JW; Parikh, UM; Penrose, KJ	1
Atujuna, M; Mirembe, BG; Montgomery, ET; Palanee-Phillips, T; Pleasants, E; Reddy, K; Tauya, T; Woeber, K; Zimba, C	1
Gardiner, E; Glaubius, R; Kripke, K; Pretorius, C; Reidy, M; Torjesen, K	1
Devlin, B; Moncla, BJ; Patel, SK; Regev, G; Rohan, LC; Twist, J	1
Bumpus, NN; Hendrix, CW; To, EE	1
Devlin, B; Nuttall, J; Rosenberg, Z; Wilder, S; Woodsong, C	1
Amiji, M; Andrade, F; Araújo, F; Bahia, MF; das Neves, J; Sarmento, B	1
McGowan, I	1
Akil, A; Cost, M; Devlin, B; Rohan, LC	1
Brochard, P; Dereuddre-Bosquet, N; Desjardins, D; Feyaerts, M; Lagatie, O; Le Grand, R; Malcolm, RK; Murphy, DJ; Perrot, L; Pruvost, A; van Roey, J; Vanhooren, L	1
Agashe, H; Akil, A; Devlin, B; Dezzutti, CS; Hillier, SL; Moncla, BJ; Rohan, LC; Shi, Y; Uranker, K	1
Cameron, D; Dias, N; Dreier, P; Holding, J; Holt, JD; Muntendam, A; Nuttall, J; Oostebring, F; Rohan, L	1
Agaba, SK; Crucitti, T; De Baetselier, I; Delvaux, T; Jespers, V; Kestelyn, E; Menten, J; Schurmans, C; van de Wijgert, J; van Loen, H	1
Baeten, J; Bekker, LG; Brown, ER; Gaffoor, Z; Govender, V; Husnik, MJ; Jeenarain, N; Kiweewa, FM; Makanani, B; Martinson, F; Mgodi, N; Mhlanga, F; Naidoo, S; Nair, G; Palanee-Phillips, T; Pather, A; Phillip, J; Schwartz, K; Siva, S; Soto-Torres, L; van der Straten, A	1
Brown, ER; Devlin, B; Dezzutti, CS; Moncla, B; Nuttall, J; Rohan, LC; Teeple, EA; Wang, L; Yandura, S	1
Bunge, KE; Devlin, B; Dezzutti, CS; Hendrix, CW; Hillier, SL; Marzinke, MA; Meyn, LA; Moncla, BJ; Richardson-Harman, N; Rohan, LC; Spiegel, HM	1
das Neves, J; Martins, JP; Sarmento, B	1
Chen, BA; Cheng, H; Hoesley, CJ; Horn, S; Husnik, MJ; Laborde, N; Nel, A; Panther, L; Soto-Torres, L; van der Straten, A	1
Baeten, JM; Bekker, LG; Berthiaume, J; Brown, ER; Bunge, K; Chakhtoura, N; Chirenje, ZM; Gaffoor, Z; Galaska, B; Germuga, D; Govender, V; Grossman, CI; Hendrix, CW; Hillier, S; Husnik, M; Jacobson, C; Jeenarain, N; Jones, J; Livant, E; Makanani, B; Martinson, F; Marzinke, MA; Matovu Kiweewa, F; Mayo, A; McGowan, I; Mellors, JW; Mensch, BS; Mgodi, NM; Mhlanga, F; Montgomery, ET; Naidoo, L; Nair, G; Nakabiito, C; Ndase, P; Nel, A; Palanee-Phillips, T; Parikh, UM; Pather, A; Patterson, K; Ramjee, G; Richardson, BA; Rosenberg, Z; Scheckter, R; Schwartz, K; Singh, D; Siva, S; Soto-Torres, LE; Szydlo, DW; Taha, TE; Torjesen, K; van der Straten, A; White, R	1
Derrick, T; Devlin, B; Nel, A; Spence, P; van Niekerk, N; Wilder, S	1
Brimer, A; Devlin, B; Major, I; McConville, C	1
Oberhofer, E	1
Chen, BA; Dezzutti, CS; Hoesley, CJ; Johnson, S; Marzinke, MA; Nel, A; Nuttall, JP; Panther, L; Richardson-Harman, N; Rohan, LC	1
Bekker, LG; Borremans, M; Carstens, H; Devlin, B; Gama, C; Gill, K; Isaacs, M; Kamali, A; Kapiga, S; Kotze, P; Kusemererwa, S; Louw, C; Mabude, Z; Malherbe, M; Mans, W; Miti, N; Nel, A; Ntshele, S; Nuttall, J; Parys, W; Resseler, S; Rosenberg, Z; Russell, M; Smit, M; Solai, L; Spence, P; Steytler, J; Tempelman, H; Van Baelen, B; van Niekerk, N; Van Roey, J; Vangeneugden, T; Windle, K	1
Coplan, P; Geubbels, E; Kapiga, SH; Kiwelu, I; Masenga, G; Moyes, J; Nel, AM; Rees, HV; Smythe, SC; van de Wijgert, JH; von Mollendorf, C; Vyankandondera, J	1
Malcolm, K; McCoy, C; Nel, A; Romano, J; Rosenberg, Z; Smythe, S; Young, K	1
Kaptur, PE; Mertenskoetter, T	1
Colby-Germinario, SP; Schachter, JR; Schader, SM; Wainberg, MA; Xu, H	1
Colby-Germinario, SP; Ibanescu, RI; Moisi, D; Oliveira, M; Schader, SM; Wainberg, MA	1
Szpir, M; Van Damme, L	1
purslow, C	1
Boyd, P; Cohen, J; Kilbourne-Brook, M; Major, I; Malcolm, RK; Saxon, G	1
Ampofo, S; Boyd, P; Edwards, KL; Fetherston, SM; Malcolm, RK; McBride, MC; McCoy, CF	1
Balzarini, J; Fransen, K; Janssen, P; Kestens, L; Lewi, P; Michiels, J; Van Herrewege, Y; Van Roey, J; Vanham, G	1
Fransen, K; Garcia, S; Janssen, CG; Janssen, PA; Kestens, L; Lewi, PJ; Njai, HF; Vanham, G	1
Malcolm, RK; McCullagh, SD; Morrow, RJ; Toner, CF; Woolfson, AD	2
Beets, GI; Buvé, AM; Jespers, VA; Van Roey, JM	1
Aliyar, HA; Gupta, KM; Kiser, PF; Mitchnik, MA; Pearce, SM; Poursaid, AE; Tresco, PA	1
Cara, A; Costi, R; Di Santo, R; Hazuda, D; Lewi, P; Terrazas-Aranda, K; Van Herrewege, Y; Vanham, G	1

Reviews

11 review(s) available for dapivirine and HIV Infections

Article	Year
In search of a novel anti-HIV drug: multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, rilpivirine). Journal of medicinal chemistry, 2005, Mar-24, Volume: 48, Issue:6 Topics: Administration, Oral; Anti-HIV Agents; Biological Availability; Crystallography, X-Ray; Drug Design; Drug Evaluation, Preclinical; Genome, Viral; HIV; HIV Infections; Humans; Interdisciplinary Communication; Models, Molecular; Molecular Structure; Mutation; Nitriles; Pyrimidines; Rilpivirine	2005
Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors. European journal of medicinal chemistry, 2018, Oct-05, Volume: 158 Topics: Anti-HIV Agents; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Docking Simulation; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship	2018
Introducing the Dapivirine Vaginal Ring in Sub-Saharan Africa: What Can We Learn from Oral PrEP? Current HIV/AIDS reports, 2021, Volume: 18, Issue:6 Topics: Africa South of the Sahara; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; Pyrimidines	2021
Topical delivery of long-acting antiretrovirals to prevent HIV acquisition. Current opinion in HIV and AIDS, 2020, Volume: 15, Issue:1 Topics: Administration, Topical; Anti-Retroviral Agents; Contraceptive Devices, Female; Drug Delivery Systems; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; Pyrimidines	2020
Topical microbicides for preventing sexually transmitted infections. The Cochrane database of systematic reviews, 2021, 03-13, Volume: 3 Topics: Acrylic Resins; Adenine; Administration, Intravaginal; Agaricales; Anti-HIV Agents; Anti-Infective Agents, Local; Bias; Cellulose; Female; HIV Infections; Humans; Naphthalenesulfonates; Placebos; Polymers; Pyrimidines; Seaweed; Sexually Transmitted Diseases; Tenofovir	2021
The microbiome and HIV prevention strategies in women. Current opinion in HIV and AIDS, 2018, Volume: 13, Issue:1 Topics: Anti-Retroviral Agents; Female; Gardnerella vaginalis; HIV Infections; Humans; Microbiota; Pre-Exposure Prophylaxis; Pyrimidines; Tenofovir; Treatment Failure; Vagina; Vaginosis, Bacterial	2018
Development of dapivirine vaginal ring for HIV prevention. Antiviral research, 2013, Volume: 100 Suppl Topics: Animals; Anti-HIV Agents; Clinical Trials as Topic; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Pyrimidines	2013
An overview of antiretroviral pre-exposure prophylaxis of HIV infection. American journal of reproductive immunology (New York, N.Y. : 1989), 2014, Volume: 71, Issue:6 Topics: Adenine; Anti-HIV Agents; Cyclohexanes; Drug Resistance, Viral; Female; HIV Infections; Humans; Male; Maraviroc; Medication Adherence; Nitriles; Organophosphonates; Pre-Exposure Prophylaxis; Pyridones; Pyrimidines; Reverse Transcriptase Inhibitors; Rilpivirine; Tenofovir; Triazoles	2014
Will dapivirine redeem the promises of anti-HIV microbicides? Overview of product design and clinical testing. Advanced drug delivery reviews, 2016, 08-01, Volume: 103 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Drug Design; Female; HIV Infections; Humans; Pyrimidines	2016
Update on microbicide research and development - seeking new HIV prevention tools for women. European journal of medical research, 2011, Jan-27, Volume: 16, Issue:1 Topics: Adenine; Administration, Intravaginal; Adult; Africa South of the Sahara; Anti-HIV Agents; Anti-Infective Agents; Clinical Trials as Topic; Cyclohexanes; Drug Discovery; Female; HIV Infections; Humans; Male; Maraviroc; Organophosphonates; Pyridines; Pyrimidines; Tenofovir; Triazoles; Urea	2011
Current status of topical antiretroviral chemoprophylaxis. Current opinion in HIV and AIDS, 2012, Volume: 7, Issue:6 Topics: Adenine; Administration, Intravaginal; Administration, Topical; Anilides; Anti-HIV Agents; Chemoprevention; Clinical Trials, Phase II as Topic; Female; Furans; HIV Infections; Humans; Organophosphonates; Pyrimidines; Tenofovir; Thioamides; Treatment Outcome	2012

Trials

54 trial(s) available for dapivirine and HIV Infections

Article	Year
A Randomized, Double Blind, Placebo-Controlled, Phase 1 Safety, and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults (MTN-026). AIDS research and human retroviruses, 2022, Volume: 38, Issue:4 Topics: Adult; Anti-HIV Agents; Female; Gels; HIV Infections; HIV-1; Humans; Male; Pyrimidines; United States	2022
Integration of a Relationship-focused Counseling Intervention with Delivery of the Dapivirine Ring for HIV Prevention to Women in Johannesburg: Results of the CHARISMA Pilot Study. AIDS and behavior, 2022, Volume: 26, Issue:3 Topics: Counseling; Female; HIV Infections; Humans; Intimate Partner Violence; Male; Pilot Projects; Pyrimidines; Sexual Partners; South Africa	2022
Acceptability of a Dapivirine/Placebo Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-026). AIDS and behavior, 2022, Volume: 26, Issue:5 Topics: Adult; Anti-Infective Agents; Female; Gels; HIV Infections; HIV-1; Humans; Male; Pyrimidines; United States	2022
Does the Ring Work? Perceptions and Understanding of the Efficacy of a Dapivirine Vaginal Ring for HIV Prevention Amongst Women in a Placebo-Controlled Trial. AIDS and behavior, 2022, Volume: 26, Issue:5 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pyrimidines	2022
Impact and experience of participant engagement activities in supporting dapivirine ring use among participants enrolled in the phase III MTN-020/ASPIRE study. BMC public health, 2021, 11-08, Volume: 21, Issue:1 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pyrimidines	2021
HIV-1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial. Journal of the International AIDS Society, 2021, Volume: 24, Issue:11 Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; HIV-1; Humans; Mutation; Pyrimidines; Reverse Transcriptase Inhibitors	2021
Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women. AIDS patient care and STDs, 2022, Volume: 36, Issue:3 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Male; Postmenopause; Pyrimidines	2022
Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial. Journal of acquired immune deficiency syndromes (1999), 2022, 08-01, Volume: 90, Issue:4 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Pyrimidines; South Africa	2022
Women's experience receiving drug feedback and adherence counseling in MTN-025/HOPE - an HIV Prevention open-label trial of the Dapivirine Vaginal Ring. AIDS and behavior, 2022, Volume: 26, Issue:11 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Counseling; Feedback; Female; HIV Infections; Humans; Pyrimidines; Research Design	2022
Correlates of Dapivirine Vaginal Ring Acceptance among Women Participating in an Open Label Extension Trial. AIDS and behavior, 2023, Volume: 27, Issue:3 Topics: Adult; Africa; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Male; Pyrimidines	2023
MTN-033: a Phase 1 Study Comparing Applicator versus "as Lubricant" Delivery of Rectal Dapivirine Gel. Antimicrobial agents and chemotherapy, 2022, 11-15, Volume: 66, Issue:11 Topics: Anti-HIV Agents; Cross-Over Studies; Female; Gels; HIV Infections; Humans; Lubricants; Male; Pyrimidines; Reverse Transcriptase Inhibitors	2022
Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 03-21, Volume: 76, Issue:6 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA	2023
Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study). PloS one, 2023, Volume: 18, Issue:6 Topics: Adolescent; Anti-HIV Agents; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; Pregnancy; South Africa; Uganda; Young Adult; Zimbabwe	2023
Acceptability and Use of the Dapivirine Vaginal Ring and Daily Oral Pre-exposure Prophylaxis (PrEP) During Breastfeeding in South Africa, Malawi, Zimbabwe, and Uganda. AIDS and behavior, 2023, Volume: 27, Issue:12 Topics: Anti-HIV Agents; Breast Feeding; Contraceptive Devices, Female; Female; HIV Infections; Humans; Infant; Malawi; Pre-Exposure Prophylaxis; South Africa; Uganda; Zimbabwe	2023
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial. The lancet. HIV, 2023, Volume: 10, Issue:12 Topics: Adolescent; Anti-HIV Agents; Cross-Over Studies; Emtricitabine; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; Reverse Transcriptase Inhibitors; South Africa; Tenofovir	2023
DELIVER: A Safety Study of a Dapivirine Vaginal Ring and Oral PrEP for the Prevention of HIV During Pregnancy. Journal of acquired immune deficiency syndromes (1999), 2024, Jan-01, Volume: 95, Issue:1 Topics: Emtricitabine; Female; Gestational Age; HIV Infections; Humans; Malawi; Pregnancy; Tenofovir	2024
Impact of Male Partner Involvement on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III HIV Prevention Trial. AIDS and behavior, 2020, Volume: 24, Issue:5 Topics: Adolescent; Adult; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Malawi; Male; Pyrimidines; South Africa; Uganda; Young Adult; Zimbabwe	2020
Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities. AIDS (London, England), 2020, 03-15, Volume: 34, Issue:4 Topics: Adult; Anti-HIV Agents; Contraceptive Devices, Female; Double-Blind Method; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Pyrimidines; Vagina; Young Adult	2020
Brief Report: Anal Intercourse, HIV-1 Risk, and Efficacy in a Trial of a Dapivirine Vaginal Ring for HIV-1 Prevention. Journal of acquired immune deficiency syndromes (1999), 2020, 03-01, Volume: 83, Issue:3 Topics: Administration, Intravaginal; Africa South of the Sahara; Anti-HIV Agents; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Male; Pyrimidines; Sexual Behavior	2020
Validation and implementation of an ultrasensitive liquid chromatographic-tandem mass spectrometric (LC-MS/MS) assay for dapivirine quantitation in breast milk. Clinical biochemistry, 2020, Volume: 82 Topics: Administration, Intravaginal; Anti-HIV Agents; Chromatography, High Pressure Liquid; Data Accuracy; Female; HIV Infections; HIV-1; Humans; Lactation; Milk, Human; Pyrimidines; Reproducibility of Results; Solid Phase Extraction; Tandem Mass Spectrometry	2020
Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women. Journal of acquired immune deficiency syndromes (1999), 2020, 02-01, Volume: 83, Issue:2 Topics: Adolescent; Adult; Anti-HIV Agents; Contraceptive Devices, Female; Dose-Response Relationship, Drug; Double-Blind Method; Female; HIV Infections; Humans; Placebos; Plasma; Pyrimidines; Self Report; United States; Vagina; Young Adult	2020
The Power of the Shared Experience: MTN-020/ASPIRE Trial Participants' Descriptions of Peer Influence on Acceptability of and Adherence to the Dapivirine Vaginal Ring for HIV Prevention. AIDS and behavior, 2020, Volume: 24, Issue:8 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Peer Influence; Pyrimidines; Retrospective Studies	2020
Performance and Acceptability of the FC2 Female Condom When Used With and Without a Silicone Placebo Vaginal Ring-A Randomized, Crossover Trial. Journal of acquired immune deficiency syndromes (1999), 2020, 09-01, Volume: 85, Issue:1 Topics: Adult; Anti-HIV Agents; Condoms, Female; Contraceptive Devices, Female; Cross-Over Studies; Female; HIV Infections; Humans; Male; Middle Aged; Pyrimidines; United States; Young Adult	2020
Influence of dapivirine vaginal ring use on cervicovaginal immunity and functional microbiome in adolescent girls. AIDS (London, England), 2021, 03-01, Volume: 35, Issue:3 Topics: Adolescent; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Lactobacillus; Microbiota; Pyrimidines; Vagina	2021
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study. The lancet. HIV, 2021, Volume: 8, Issue:2 Topics: Administration, Intravaginal; Adolescent; Adult; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Middle Aged; Patient Compliance; Patient Safety; Pyrimidines; Seroconversion; South Africa; Tenofovir; Treatment Outcome; Uganda	2021
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. The lancet. HIV, 2021, Volume: 8, Issue:2 Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Malawi; Patient Compliance; Patient Safety; Pyrimidines; Seroconversion; South Africa; Tenofovir; Treatment Outcome; Uganda; Zimbabwe	2021
Assessment of risk compensation following use of the dapivirine vaginal ring in southwestern Uganda. Sexually transmitted infections, 2022, Volume: 98, Issue:1 Topics: Adult; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pyrimidines; Risk Factors; Sexual Behavior; Young Adult	2022
Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. AIDS and behavior, 2021, Volume: 25, Issue:8 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Pyrimidines	2021
Culturally-Based Challenges to and Recommendations for Delivering Adherence Counseling in a Multicultural Biomedical HIV Prevention Trial in Four African Countries. AIDS education and prevention : official publication of the International Society for AIDS Education, 2020, Volume: 32, Issue:6 Topics: Adult; Anti-Infective Agents; Communication Barriers; Counseling; Cultural Characteristics; Culturally Competent Care; Educational Status; Female; HIV Infections; Humans; Malawi; Medication Adherence; Motivational Interviewing; Pyrimidines; South Africa; Surveys and Questionnaires; Uganda; Zimbabwe	2020
The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence. AIDS and behavior, 2021, Volume: 25, Issue:12 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Disclosure; Female; HIV Infections; Humans; Pyrimidines	2021
Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa. AIDS and behavior, 2021, Volume: 25, Issue:12 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Malawi; Pyrimidines	2021
Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention. AIDS and behavior, 2021, Volume: 25, Issue:9 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Pyrimidines	2021
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States. Journal of the International AIDS Society, 2021, Volume: 24, Issue:6 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pyrimidines; United States	2021
Acceptability and use of a dapivirine vaginal ring in a phase III trial. AIDS (London, England), 2017, 05-15, Volume: 31, Issue:8 Topics: Adolescent; Adult; Africa; Anti-HIV Agents; Chemoprevention; Contraceptive Devices, Female; Female; HIV Infections; Humans; Interviews as Topic; Middle Aged; Patient Acceptance of Health Care; Pyrimidines; Young Adult	2017
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception. Journal of acquired immune deficiency syndromes (1999), 2017, 10-01, Volume: 76, Issue:2 Topics: Adolescent; Adult; Anti-Retroviral Agents; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pregnancy; Pyrimidines; Young Adult	2017
Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial. Journal of acquired immune deficiency syndromes (1999), 2017, 11-01, Volume: 76, Issue:3 Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Feasibility Studies; Female; HIV Infections; HIV-1; Humans; Medication Adherence; Monitoring, Physiologic; Pre-Exposure Prophylaxis; Pyrimidines; Young Adult	2017
Reasons for nonadherence to the dapivirine vaginal ring: narrative explanations of objective drug-level results. AIDS (London, England), 2018, 07-17, Volume: 32, Issue:11 Topics: Adolescent; Adult; Africa; Anti-HIV Agents; Contraceptive Devices, Female; Double-Blind Method; HIV Infections; Humans; Interviews as Topic; Middle Aged; Patient Acceptance of Health Care; Patient Compliance; Pre-Exposure Prophylaxis; Pyrimidines; Young Adult	2018
Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE. AIDS and behavior, 2019, Volume: 23, Issue:2 Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Malawi; Patient Compliance; Pyrimidines; Self Report; South Africa; Uganda; Young Adult; Zimbabwe	2019
Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial. Journal of acquired immune deficiency syndromes (1999), 2018, 12-15, Volume: 79, Issue:5 Topics: Adult; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Intimate Partner Violence; Medication Adherence; Pyrimidines; Young Adult	2018
Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 07-18, Volume: 69, Issue:3 Topics: Adult; Africa; Anti-HIV Agents; Contraceptive Devices, Female; Disease Progression; Female; HIV; HIV Infections; HIV Seropositivity; Humans; Pyrimidines; Reverse Transcriptase Inhibitors; Vagina; Young Adult	2019
Pregnancy and Infant Outcomes Among Women Using the Dapivirine Vaginal Ring in Early Pregnancy. Journal of acquired immune deficiency syndromes (1999), 2018, 12-15, Volume: 79, Issue:5 Topics: Adolescent; Adult; Africa South of the Sahara; Anti-HIV Agents; Child Development; Contraceptive Devices, Female; Double-Blind Method; Female; HIV Infections; Humans; Infant, Newborn; Middle Aged; Placebos; Pregnancy; Pregnancy Outcome; Pyrimidines; Young Adult	2018
Pharmacokinetics of Dapivirine Transfer into Blood Plasma, Breast Milk, and Cervicovaginal Fluid of Lactating Women Using the Dapivirine Vaginal Ring. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:3 Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Female; HIV Infections; Humans; Lactation; Milk, Human; Pyrimidines; Young Adult	2019
Negative rumours about a vaginal ring for HIV-1 prevention in sub-Saharan Africa. Culture, health & sexuality, 2019, Volume: 21, Issue:11 Topics: Adult; Anti-Retroviral Agents; Contraceptive Devices, Female; Deception; Female; Focus Groups; HIV Infections; HIV-1; Humans; Interviews as Topic; Malawi; Patient Acceptance of Health Care; Pyrimidines; South Africa; Zimbabwe	2019
First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring. Journal of acquired immune deficiency syndromes (1999), 2019, 07-01, Volume: 81, Issue:3 Topics: Adolescent; Adult; Africa South of the Sahara; Anti-HIV Agents; Anxiety; Contraceptive Devices, Female; Double-Blind Method; Female; HIV Infections; Humans; Middle Aged; Patient Compliance; Pyrimidines; Young Adult	2019
The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy. BMC public health, 2015, Apr-10, Volume: 15 Topics: Adult; Anti-HIV Agents; Contraception; Contraceptive Devices, Female; Female; HIV Infections; Humans; Menstruation; Pregnancy; Pregnancy, Unplanned; Pyrimidines; Research Design; Rwanda	2015
Characteristics of Women Enrolled into a Randomized Clinical Trial of Dapivirine Vaginal Ring for HIV-1 Prevention. PloS one, 2015, Volume: 10, Issue:6 Topics: Adolescent; Adult; Africa South of the Sahara; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Middle Aged; Pyrimidines; Vagina; Young Adult	2015
A Phase 1 Trial to Assess the Safety, Acceptability, Pharmacokinetics, and Pharmacodynamics of a Novel Dapivirine Vaginal Film. Journal of acquired immune deficiency syndromes (1999), 2016, Apr-15, Volume: 71, Issue:5 Topics: Administration, Intravaginal; Adult; Anti-HIV Agents; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Pyrimidines; Reverse Transcriptase Inhibitors; Vaginal Creams, Foams, and Jellies	2016
Adherence and Acceptability of a Multidrug Vaginal Ring for HIV Prevention in a Phase I Study in the United States. AIDS and behavior, 2016, Volume: 20, Issue:11 Topics: Adult; Anti-HIV Agents; Contraceptive Devices, Female; Cyclohexanes; Double-Blind Method; Drug Therapy, Combination; Feasibility Studies; Female; HIV Infections; Humans; Interview, Psychological; Maraviroc; Medication Adherence; Patient Acceptance of Health Care; Pre-Exposure Prophylaxis; Program Evaluation; Pyrimidines; South Africa; Text Messaging; Triazoles	2016
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. The New England journal of medicine, 2016, 12-01, Volume: 375, Issue:22 Topics: Adolescent; Adult; Africa, Southern; Age Factors; Double-Blind Method; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Incidence; Middle Aged; Patient Compliance; Pyrimidines; Reverse Transcriptase Inhibitors; Vagina; Young Adult	2016
Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and/or maraviroc in a randomized, placebo controlled trial. Medicine, 2016, Volume: 95, Issue:28 Topics: Administration, Intravaginal; Adult; Biopsy; Cervix Uteri; Contraceptive Devices, Female; Cryopreservation; Cyclohexanes; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; In Vitro Techniques; Maraviroc; Pyrimidines; Sexually Transmitted Diseases, Viral; Triazoles; United States	2016
Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women. The New England journal of medicine, 2016, 12-01, Volume: 375, Issue:22 Topics: Adolescent; Adult; Double-Blind Method; Drug Resistance, Viral; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Incidence; Middle Aged; Pregnancy; Pyrimidines; Reverse Transcriptase Inhibitors; RNA, Viral; South Africa; Uganda; Vagina; Young Adult	2016
Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women. AIDS (London, England), 2009, Jul-31, Volume: 23, Issue:12 Topics: Administration, Intravaginal; Adolescent; Adult; Anti-HIV Agents; Cervix Uteri; Dose-Response Relationship, Drug; Double-Blind Method; Female; HIV Infections; HIV Reverse Transcriptase; Humans; Middle Aged; Patient Compliance; Patient Satisfaction; Pyrimidines; Vagina; Vaginal Creams, Foams, and Jellies; Vulva; Young Adult	2009
Safety and pharmacokinetics of dapivirine delivery from matrix and reservoir intravaginal rings to HIV-negative women. Journal of acquired immune deficiency syndromes (1999), 2009, Aug-01, Volume: 51, Issue:4 Topics: Administration, Intravaginal; Adolescent; Adult; Colposcopy; Double-Blind Method; Female; HIV Infections; Humans; Pyrimidines; Reverse Transcriptase Inhibitors; Vagina	2009
Dose-ranging phase 1 study of TMC120, a promising vaginal microbicide, in HIV-negative and HIV-positive female volunteers. Journal of acquired immune deficiency syndromes (1999), 2007, Feb-01, Volume: 44, Issue:2 Topics: Adolescent; Adult; Anti-HIV Agents; Cervix Uteri; Colposcopy; Double-Blind Method; Erythema; Female; HIV Infections; Humans; Middle Aged; Purpura; Pyrimidines; Vaginal Creams, Foams, and Jellies	2007

Other Studies

57 other study(ies) available for dapivirine and HIV Infections

Article	Year
Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Anti-HIV Agents; Cells, Cultured; Cervix Uteri; Dose-Response Relationship, Drug; Female; HIV Infections; HIV-1; Humans; Luciferases; Macrophages; Organ Culture Techniques; Pyrimidines; Reverse Transcriptase Inhibitors; T-Lymphocytes	2009
Reverse transcriptase inhibitors as potential colorectal microbicides. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Adenine; Anilides; Anti-HIV Agents; Anti-Infective Agents, Local; Colon; Drug Resistance, Viral; Furans; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Organophosphonates; Pyrimidines; Rectum; Reverse Transcriptase Inhibitors; Tenofovir; Thioamides; Tissue Culture Techniques; Virus Replication	2009
Discovery of diarylpyridine derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorganic & medicinal chemistry letters, 2009, Sep-15, Volume: 19, Issue:18 Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Pyridines; Structure-Activity Relationship	2009
Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study). AIDS education and prevention : official publication of the International Society for AIDS Education, 2021, Volume: 33, Issue:5 Topics: Administration, Rectal; Adult; HIV Infections; HIV-1; Homosexuality, Male; Humans; Male; Pyrimidines; Sexual and Gender Minorities	2021
Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance. Drug delivery and translational research, 2023, Volume: 13, Issue:8 Topics: 2-Propanol; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Vagina	2023
Ring-ing in the Future: Participant and Male Partner Perspectives Regarding Future Use of the Dapivirine Vaginal Ring for HIV Prevention. AIDS and behavior, 2022, Volume: 26, Issue:6 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Male; Pyrimidines	2022
Efficacy and Action of the Dapivirine Vaginal Ring as Understood by Women Participating in an Open Label Extension Study. AIDS and behavior, 2023, Volume: 27, Issue:1 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; South Africa; Uganda	2023
U.S. Women Need the Dapivirine Ring, Too: FDA as Structural Barrier to HIV Prevention for Women. AIDS education and prevention : official publication of the International Society for AIDS Education, 2022, Volume: 34, Issue:4 Topics: Anti-HIV Agents; Anti-Infective Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pyrimidines; United States	2022
Brief Report: Dapivirine Ring HIV-1 Prevention Effectiveness for Women Engaged in Vaginal and Anal Intercourse: Insights From Mathematical Modeling. Journal of acquired immune deficiency syndromes (1999), 2023, 02-01, Volume: 92, Issue:2 Topics: Anti-HIV Agents; Clinical Trials as Topic; Contraceptive Devices, Female; Female; HIV Infections; HIV Seropositivity; HIV-1; Humans; Sexual Behavior	2023
Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials-The Ring Study and DREAM. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 02-08, Volume: 76, Issue:3 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV Seropositivity; Humans; Reverse Transcriptase Inhibitors; RNA; Viral Load	2023
Male Partner Opinions of the Dapivirine Vaginal Ring Used During an Open-Label Extension HIV Prevention Trial in KwaZulu-Natal, South Africa. Journal of acquired immune deficiency syndromes (1999), 2023, 02-01, Volume: 92, Issue:2 Topics: Adult; Anti-HIV Agents; Clinical Trials, Phase III as Topic; Contraceptive Devices, Female; HIV Infections; Humans; Male; Middle Aged; Multicenter Studies as Topic; Pyrimidines; South Africa; Young Adult	2023
Adolescent Girls and Young Women's Experiences with Disclosing Oral PrEP or Dapivirine Vaginal Ring Use: a Multi-Country Qualitative Analysis. AIDS and behavior, 2023, Volume: 27, Issue:12 Topics: Adolescent; Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; Pyrimidines	2023
Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring Trial. Journal of acquired immune deficiency syndromes (1999), 2024, Jan-01, Volume: 95, Issue:1 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; HIV Seropositivity; Humans; Retrospective Studies; Reverse Transcriptase Inhibitors	2024
Two into one does go: Formulation development of a multipurpose combination vaginal ring releasing dapivirine and metronidazole for prevention of HIV infection and treatment of bacterial vaginosis. International journal of pharmaceutics, 2023, Dec-15, Volume: 648 Topics: Contraceptive Devices, Female; Female; HIV Infections; Humans; Metronidazole; Vagina; Vaginosis, Bacterial	2023
Combination of G2-S16 dendrimer/dapivirine antiretroviral as a new HIV-1 microbicide. Future medicinal chemistry, 2019, Volume: 11, Issue:23 Topics: Animals; Anti-HIV Agents; Bacteria, Anaerobic; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; Dendrimers; Dose-Response Relationship, Drug; Drug Synergism; Epithelial Cells; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Polyelectrolytes; Polymers; Pyrimidines; Silanes; Vero Cells	2019
Client-Centered Adherence Counseling with Adherence Measurement Feedback to Support Use of the Dapivirine Ring in MTN-025 (The HOPE Study). AIDS and behavior, 2021, Volume: 25, Issue:2 Topics: Counseling; Feedback; Female; HIV Infections; Humans; Pyrimidines	2021
Maraviroc, tenofovir disoproxil fumarate and dapivirine, activate progesterone receptor B in the absence of progestogens. Biochemical and biophysical research communications, 2020, 12-17, Volume: 533, Issue:4 Topics: Anti-HIV Agents; Binding, Competitive; Cell Line; Contraceptive Agents, Hormonal; HIV Infections; HIV-1; Humans; Immunologic Factors; In Vitro Techniques; Levonorgestrel; Maraviroc; Phosphorylation; Progesterone Congeners; Pyrimidines; Receptors, Progesterone; Tenofovir; Transcriptional Activation	2020
Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial. Journal of the International AIDS Society, 2020, Volume: 23, Issue:11 Topics: Adolescent; Adult; Anti-HIV Agents; Contraceptive Devices, Female; Drug Liberation; Female; HIV Infections; HIV-1; Humans; Medication Adherence; Middle Aged; Pre-Exposure Prophylaxis; Pyrimidines; Randomized Controlled Trials as Topic; Risk Reduction Behavior; Sexual Behavior; Young Adult	2020
Qualitative Perceptions of Dapivirine VR Adherence and Drug Level Feedback Following an Open-Label Extension Trial. Journal of acquired immune deficiency syndromes (1999), 2021, 04-01, Volume: 86, Issue:4 Topics: Administration, Intravaginal; Adult; Africa South of the Sahara; Anti-HIV Agents; Contraceptive Devices, Female; HIV Infections; HIV-1; Humans; Medication Adherence; Middle Aged; Pyrimidines	2021
Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe. AIDS and behavior, 2021, Volume: 25, Issue:6 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Malawi; Male; Pyrimidines; Sexual Behavior; Sexual Partners; South Africa; Uganda; Zimbabwe	2021
In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection. International journal of nanomedicine, 2021, Volume: 16 Topics: Anti-HIV Agents; Anti-Retroviral Agents; Cell Death; Cell Line; Drug Compounding; Drug Liberation; Drug Synergism; Female; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Lectins; Nanoparticles; Particle Size; Plant Lectins; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Raltegravir Potassium; Recombinant Proteins; Tenofovir	2021
HIV prevention at drug shops: awareness and attitudes among shop dispensers and young women about oral pre-exposure prophylaxis and the dapivirine ring in Shinyanga, Tanzania. AIDS research and therapy, 2021, 04-26, Volume: 18, Issue:1 Topics: Adolescent; Adult; Anti-HIV Agents; Child; Female; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Infant, Newborn; Pharmaceutical Preparations; Pre-Exposure Prophylaxis; Pyrimidines; Tanzania; Young Adult	2021
Using Emoji Stickers to Understand End-User Opinions of the Dapivirine Vaginal Ring for HIV Prevention. AIDS and behavior, 2021, Volume: 25, Issue:12 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pyrimidines	2021
Packing Polymorphism of Dapivirine and Its Impact on the Performance of a Dapivirine-Releasing Silicone Elastomer Vaginal Ring. Journal of pharmaceutical sciences, 2017, Volume: 106, Issue:8 Topics: Anti-HIV Agents; Contraceptive Devices, Female; Drug Delivery Systems; Drug Liberation; Female; HIV Infections; Humans; Powder Diffraction; Pyrimidines; Silicone Elastomers; Solubility; Thermodynamics; X-Ray Diffraction	2017
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:7 Topics: Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; Humans; Pyridines; Pyrimidines; Reproductive Tract Infections; Reverse Transcriptase Inhibitors; Rilpivirine; Urea	2017
Attitudes and perceptions towards novel objective measures of ARV-based vaginal ring use: Results from a global stakeholder survey. PloS one, 2017, Volume: 12, Issue:7 Topics: Adolescent; Adult; Anti-Retroviral Agents; Attitude; Contraceptive Devices, Female; Electronic Mail; Female; Hair; HIV Infections; Humans; Male; Perception; Pyrimidines; Surveys and Questionnaires; Young Adult	2017
Performance of a Validated Risk Score to Predict HIV-1 Acquisition Among African Women Participating in a Trial of the Dapivirine Vaginal Ring. Journal of acquired immune deficiency syndromes (1999), 2018, 01-01, Volume: 77, Issue:1 Topics: Adult; Africa, Eastern; Africa, Southern; Anti-HIV Agents; Contraceptive Devices, Female; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Patient Compliance; Pre-Exposure Prophylaxis; Pyrimidines; Validation Studies as Topic; Young Adult	2018
Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex. AIDS and behavior, 2018, Volume: 22, Issue:2 Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Infective Agents; Coitus; Contraceptive Devices, Female; Female; HIV Infections; Humans; Malawi; Patient Acceptance of Health Care; Pyrimidines; Sexual Behavior; Sexual Partners; South Africa; Uganda; Zimbabwe	2018
Physiologically-based pharmacokinetic model of vaginally administered dapivirine ring and film formulations. British journal of clinical pharmacology, 2018, Volume: 84, Issue:9 Topics: Administration, Intravaginal; Anti-HIV Agents; Female; HIV Infections; Humans; Models, Biological; Pyrimidines; Tissue Distribution; Vagina	2018
Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics. JCI insight, 2018, 07-12, Volume: 3, Issue:13 Topics: Actinobacteria; Adenine; Alanine; Anti-Retroviral Agents; Bacteria; Endocytosis; Female; Gardnerella vaginalis; HIV Infections; Humans; Hydrogen-Ion Concentration; Jurkat Cells; Lactobacillus crispatus; Microbiota; Pyrimidines; Tenofovir; Vagina	2018
Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES. International journal of pharmaceutics, 2019, Jun-10, Volume: 564 Topics: Animals; Anti-HIV Agents; Chemokines, CC; Contraceptive Devices, Female; Delayed-Action Preparations; Drug Combinations; Female; HIV Infections; Pyrimidines; Sheep; Vagina	2019
Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness. Journal of the International AIDS Society, 2019, Volume: 22, Issue:5 Topics: Adolescent; Adult; Anti-HIV Agents; Contraceptive Devices, Female; Cost-Benefit Analysis; Drug Resistance, Viral; Female; HIV Infections; Humans; Male; Middle Aged; Models, Theoretical; Pre-Exposure Prophylaxis; Pyrimidines; Sex Workers; South Africa; Young Adult	2019
Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial. AIDS and behavior, 2020, Volume: 24, Issue:3 Topics: Administration, Intravaginal; Adolescent; Adult; Anti-HIV Agents; Clinical Trials as Topic; Contraceptive Devices, Female; Female; HIV Infections; HIV-1; Humans; Interpersonal Relations; Malawi; Male; Middle Aged; Pre-Exposure Prophylaxis; Pyrimidines; Qualitative Research; Sexual Behavior; Sexual Partners; South Africa; Uganda; Vaginal Creams, Foams, and Jellies; Zimbabwe	2020
Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention. PloS one, 2019, Volume: 14, Issue:6 Topics: Adult; Africa; Anti-HIV Agents; Contraceptive Devices, Female; Cost-Benefit Analysis; Delayed-Action Preparations; Female; HIV Infections; Humans; Male; Middle Aged; Models, Biological; Pre-Exposure Prophylaxis; Pyrimidines; Risk Factors; Sex Workers; Young Adult	2019
Novel Application of Hot Melt Extrusion for the Manufacturing of Vaginal Films Containing Microbicide Candidate Dapivirine. AAPS PharmSciTech, 2019, Jun-26, Volume: 20, Issue:6 Topics: Administration, Intravaginal; Drug Liberation; Female; Freezing; HIV Infections; HIV-1; Hot Temperature; Humans; Microbial Sensitivity Tests; Pharmaceutical Preparations; Polymers; Pyrimidines; Reverse Transcriptase Inhibitors; Technology, Pharmaceutical	2019
Dissimilarities in the metabolism of antiretroviral drugs used in HIV pre-exposure prophylaxis in colon and vagina tissues. Biochemical pharmacology, 2013, Oct-01, Volume: 86, Issue:7 Topics: Adult; Anti-HIV Agents; Chemoprevention; Colon; Cyclohexanes; Cytochrome P-450 Enzyme System; Female; Glucuronosyltransferase; HIV Infections; Humans; Isoenzymes; Male; Maraviroc; Mucous Membrane; Organ Specificity; Pyrimidines; Triazoles; Vagina; Young Adult	2013
Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice. Pharmaceutical research, 2014, Volume: 31, Issue:7 Topics: Administration, Intravaginal; Animals; Female; HIV Infections; HIV Reverse Transcriptase; Mice; Nanoparticles; Polyesters; Pyrimidines; Tissue Distribution; Vagina	2014
Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir. Molecular pharmaceutics, 2014, May-05, Volume: 11, Issue:5 Topics: Adenine; Administration, Intravaginal; Anti-HIV Agents; Anti-Infective Agents; Drug Delivery Systems; Female; HIV Infections; Humans; In Vitro Techniques; Membranes, Artificial; Organophosphonates; Pyrimidines; Tenofovir; Vagina	2014
Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir. The Journal of antimicrobial chemotherapy, 2014, Volume: 69, Issue:9 Topics: Animals; Anti-HIV Agents; Body Fluids; Cervix Uteri; Contraceptive Devices, Female; Darunavir; Disease Models, Animal; Disease Transmission, Infectious; Drug Therapy, Combination; Female; HIV Infections; Humans; Inhibitory Concentration 50; Macaca; Pre-Exposure Prophylaxis; Pyrimidines; Rectum; Sulfonamides; Uterus; Vagina	2014
Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV prevention. Pharmaceutical research, 2015, Volume: 32, Issue:2 Topics: Adenine; Administration, Intravaginal; Administration, Topical; Anti-HIV Agents; Chemistry, Pharmaceutical; Drug Carriers; Drug Combinations; Drug Delivery Systems; Female; HIV Infections; HIV-1; Humans; Organophosphonates; Polymers; Pyrimidines; Tenofovir; Vagina	2015
The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:7 Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Contraceptive Devices, Female; Disease Models, Animal; Drug Carriers; Female; HIV Infections; Pyrimidines; Sheep; Tenofovir; Vagina; Vaginal Creams, Foams, and Jellies	2015
Pharmacodynamic Activity of Dapivirine and Maraviroc Single Entity and Combination Topical Gels for HIV-1 Prevention. Pharmaceutical research, 2015, Volume: 32, Issue:11 Topics: Administration, Topical; Anti-HIV Agents; Cell Survival; Cervix Uteri; Colon; Cyclohexanes; Drug Combinations; Drug Liberation; Female; Gels; HIV Fusion Inhibitors; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Maraviroc; Mucous Membrane; Pyrimidines; Rectum; Rheology; Triazoles	2015
Antiretroviral gels: facing the FACTS. The lancet. HIV, 2015, Volume: 2, Issue:4 Topics: Adult; Africa South of the Sahara; Anti-HIV Agents; Anti-Infective Agents, Local; Clinical Trials as Topic; Drug Delivery Systems; Female; Gels; HIV Infections; Humans; Medication Adherence; Pyrimidines; Sexual Behavior; Tenofovir; Women's Health	2015
Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence. Journal of pharmaceutical and biomedical analysis, 2016, Jun-05, Volume: 125 Topics: Anti-HIV Agents; Drug Administration Routes; Female; Guideline Adherence; HIV Infections; Humans; Pyrimidines; Vagina	2016
Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2016, Volume: 104 Topics: Acyclovir; Contraceptive Devices, Female; Female; HIV Infections; Humans; Levonorgestrel; Pyrimidines; Tablets; Vagina	2016
[PrEP (pre-exposure prophylaxis) for women: what are the benefits of the vaginal ring?]. MMW Fortschritte der Medizin, 2016, Jun-09, Volume: 158 Suppl 1 Topics: Administration, Intravaginal; Contraceptive Devices, Female; Female; HIV Infections; Humans; Pre-Exposure Prophylaxis; Pyrimidines	2016
Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination. AIDS (London, England), 2011, Aug-24, Volume: 25, Issue:13 Topics: Adenine; Drug Resistance, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Tenofovir	2011
In vitro resistance profile of the candidate HIV-1 microbicide drug dapivirine. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:2 Topics: Adenine; Anti-HIV Agents; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Tenofovir	2012
Researchers announce launch of latest HIV microbicide trial. Expert review of clinical pharmacology, 2012, Volume: 5, Issue:5 Topics: Adolescent; Adult; Anti-Infective Agents; Clinical Trials, Phase III as Topic; Female; HIV Infections; HIV Reverse Transcriptase; HIV Seropositivity; Humans; Middle Aged; Pyrimidines; Rwanda; South Africa; Young Adult	2012
A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine. Contraception, 2013, Volume: 88, Issue:1 Topics: Anti-HIV Agents; Calorimetry, Differential Scanning; Chemical Phenomena; Cold Temperature; Contraceptive Devices, Female; Delayed-Action Preparations; Female; HIV Infections; HIV Reverse Transcriptase; Hot Temperature; Humans; Kinetics; Materials Testing; Mechanical Phenomena; Pyrimidines; Solubility	2013
A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2013, Feb-14, Volume: 48, Issue:3 Topics: Calorimetry, Differential Scanning; CCR5 Receptor Antagonists; Contraceptive Devices, Female; Cyclohexanes; Delayed-Action Preparations; Drug Combinations; Drug Delivery Systems; Drug Stability; Drug Storage; HIV Infections; HIV Reverse Transcriptase; Hot Temperature; Maraviroc; Mechanical Phenomena; Pyrimidines; Reverse Transcriptase Inhibitors; Silicone Elastomers; Solubility; Triazoles	2013
In vitro evaluation of nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 as human immunodeficiency virus microbicides. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:1 Topics: Anilides; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cell-Free System; Cells, Cultured; Coculture Techniques; Dendritic Cells; Enzyme-Linked Immunosorbent Assay; Furans; HIV Infections; HIV-1; Humans; Pyrimidines; Reverse Transcriptase Inhibitors; Thioamides	2004
Pre-incubation of cell-free HIV-1 group M isolates with non-nucleoside reverse transcriptase inhibitors blocks subsequent viral replication in co-cultures of dendritic cells and T cells. Antiviral therapy, 2005, Volume: 10, Issue:2 Topics: CD4-Positive T-Lymphocytes; Coculture Techniques; Dendritic Cells; Dose-Response Relationship, Drug; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Nitriles; Pyridazines; Pyrimidines; Virus Replication	2005
Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. The Journal of antimicrobial chemotherapy, 2005, Volume: 56, Issue:5 Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Contraceptive Devices, Female; Delayed-Action Preparations; HIV Infections; Humans; Pyrimidines; Sexually Transmitted Diseases, Viral; Silicone Elastomers	2005
Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. International journal of pharmaceutics, 2006, Nov-15, Volume: 325, Issue:1-2 Topics: Administration, Intravaginal; Contraceptive Devices, Female; Delayed-Action Preparations; Diffusion; Dimethylpolysiloxanes; Equipment Design; Equipment Safety; Excipients; Female; HIV Infections; HIV Reverse Transcriptase; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Lactose; Molecular Structure; Myristates; Nylons; Permeability; Pyrimidines; Silicone Elastomers; Solubility; Technology, Pharmaceutical; Temperature; Time Factors	2006
Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1. Journal of pharmaceutical sciences, 2008, Volume: 97, Issue:10 Topics: Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Contraceptive Devices, Female; Drug Delivery Systems; Female; HIV Infections; Humans; Polyurethanes; Pyrimidines; Reverse Transcriptase Inhibitors	2008
Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7 Topics: Anilides; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Cell Line; Cells, Cultured; Coculture Techniques; Dendritic Cells; Female; Furans; HIV Infections; HIV Integrase Inhibitors; HIV-1; Humans; Male; Naphthyridines; Pyrimidines; Reverse Transcriptase Inhibitors; Thioamides; Virus Integration	2008